Diaphragmatic Breathing Exercises and Chronic Non-spesifik Neck and Back Pain

June 27, 2026 updated by: Kübra Canli, Hacettepe University

Effects of Diaphragmatic Breathing Exercises Added to Posture and Core Stabilization Training on Pain, Body Awareness and Cardiovascular Parameters in Women With Chronic Non-spesific Neck and Back Pain

Effects of Diaphragmatic Breathing Exercises Added to Posture and Core Stabilization Training on Pain, Body Awareness and Cardiovascular Parameters in Women with Chronic Non-spesific Neck and Back Pain

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

This study aimed to investigate additional effect of diaphragmatic breathing exercises on pain, body awareness and cardiovascular parameters in women with chronic non-spesific neck and back pain

Study Type

Interventional

Enrollment (Estimated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Ortahisar
      • Trabzon, Ortahisar, Turkey (Türkiye), 61080
        • Karadeniz Technical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Having a diagnosis of non-specific chronic neck pain (ICD-10: M54.2) and upper back pain (ICD-10: M54.6)
  • Having a Visual Analog Scale (VAS) pain score of ≥ 3/10
  • Not having received physiotherapy treatment within the previous 3 months
  • Not being a regular smoker or alcohol user

Exclusion Criteria:

  • Having a history of cervical region surgery
  • Individuals with diagnostic codes other than M54.2 and M54.6 will be excluded from the study
  • Having a history of acute infection, major surgical intervention, or malignancy within the past three months
  • Having neurological, rheumatological, or respiratory system diseases
  • Being pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Diapragmatic Breathing Group
In addition to postural and core stabilization exercises, participants in the intervention group will perform diaphragmatic breathing exercises over an 8-week period, with sessions conducted twice weekly. Each session will last approximately 40 minutes.
Other: Diapragmatic Breathing
In addition to postural and core stabilization exercises, participants in the intervention group will perform diaphragmatic breathing exercises over an 8-week period, with sessions conducted twice weekly. Each session will last approximately 40 minutes.
Active Comparator: Control Group
Participants in the control group will receive a routine exercise program consisting of postural and core stabilization exercises for 8 weeks, performed twice weekly. Each session will last approximately 30 minutes.
Other: Control Group (A):
Participants in the control group will receive a routine exercise program consisting of postural and core stabilization exercises for 8 weeks, performed twice weekly. Each session will last approximately 30 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: Baseline and at 8 weeks
Pain intensity will be assessed using the Visual Analog Scale (VAS). Participants will be asked to mark the point on a 10-cm scale that best represents the intensity of their pain, where 0 indicates "no pain" and 10 indicates "the worst pain imaginable." The distance (in centimeters) from the 0 point to the participant's mark will be measured and recorded as the VAS score.
Baseline and at 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body awareness
Time Frame: Baselien and at 8 weeks
Participants' body awareness will be assessed using the Body Awareness Questionnaire (BAQ). The Turkish version of the questionnaire was adapted by Karaca (2017), who reported excellent internal consistency (Cronbach's α = 0.91). The BAQ is an 18-item self-report instrument designed to assess individuals' awareness of their own body and internal bodily sensations. Each item is rated on a 7-point Likert scale ranging from 1 ("Never") to 7 ("Always"). Total scores range from 18 to 126, with higher scores indicating greater awareness of bodily signals.
Baselien and at 8 weeks
Blood pressure
Time Frame: Baseline and at 8 weeks
Participants will be assessed in the seated position after at least 15 minutes of rest. Blood pressure measurements will be obtained twice from the right arm using a manual sphygmomanometer. Systolic and diastolic blood pressure values will be recorded.
Baseline and at 8 weeks
Heart rate
Time Frame: Baseline and 8 weeks
Resting heart rate will be measured using a fingertip pulse oximeter
Baseline and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 29, 2026

Primary Completion (Estimated)

October 29, 2026

Study Completion (Estimated)

January 1, 2027

Study Registration Dates

First Submitted

June 27, 2026

First Submitted That Met QC Criteria

June 27, 2026

First Posted (Actual)

July 6, 2026

Study Record Updates

Last Update Posted (Actual)

July 6, 2026

Last Update Submitted That Met QC Criteria

June 27, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2026-127

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Back Pain

Clinical Trials on Diapragmatic Breathing

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe